Oscar Health (NYSE: OSCR) director sells shares after large option exercise
Rhea-AI Filing Summary
Oscar Health director Mario Schlosser reported a mix of option exercises, conversions, and open-market sales of Class A common stock. Family dynasty trusts associated with him sold an aggregate of 1,027,500 shares at weighted average prices between about $28.95 and $30.09, and he has disclaimed beneficial ownership in those trust holdings except for any pecuniary interest.
On the same date, he exercised and converted derivative securities into 2,347,500 shares, including 660,000 shares from a fully vested stock option with a $9.75 exercise price. After these direct transactions, he reports holding 480,866 Class A shares and 2,092,293 Class B shares directly. The filing states that the transactions were effected under a Rule 10b5-1 trading plan adopted on March 24, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 660,000 | $0.00 | -- |
| Exercise | Class B Common Stock | 660,000 | $9.75 | $6.43M |
| Conversion | Class B Common Stock | 880,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 50,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 50,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 47,500 | $0.00 | -- |
| Conversion | Class A Common Stock | 880,000 | $0.00 | -- |
| Sale | Class A Common Stock | 286,988 | $28.95 | $8.31M |
| Sale | Class A Common Stock | 591,213 | $29.58 | $17.49M |
| Sale | Class A Common Stock | 1,799 | $30.09 | $54K |
| Conversion | Class A Common Stock | 50,000 | $0.00 | -- |
| Sale | Class A Common Stock | 16,307 | $28.95 | $472K |
| Sale | Class A Common Stock | 33,591 | $29.58 | $994K |
| Sale | Class A Common Stock | 102 | $30.09 | $3K |
| Conversion | Class A Common Stock | 50,000 | $0.00 | -- |
| Sale | Class A Common Stock | 16,306 | $28.95 | $472K |
| Sale | Class A Common Stock | 33,592 | $29.58 | $994K |
| Sale | Class A Common Stock | 102 | $30.09 | $3K |
| Conversion | Class A Common Stock | 47,500 | $0.00 | -- |
| Sale | Class A Common Stock | 15,491 | $28.95 | $448K |
| Sale | Class A Common Stock | 31,912 | $29.58 | $944K |
| Sale | Class A Common Stock | 97 | $30.09 | $3K |
Footnotes (1)
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Includes shares to be issued in connection with the vesting of one or more restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $29.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.08 to $30.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. The stock option is fully vested and exercisable, and expires on December 16, 2029.